Analysts Set Phreesia, Inc. (NYSE:PHR) Price Target at $16.65

Shares of Phreesia, Inc. (NYSE:PHR) have earned a consensus rating of “Hold” from the nineteen brokerages that are currently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and nine have given a buy rating to the company. The average twelve-month target price among brokers that have issued a report on the stock in the last year is $16.6471.

PHR has been the subject of several research analyst reports. Wall Street Zen raised Phreesia from a “hold” rating to a “buy” rating in a report on Saturday, May 30th. Barclays reaffirmed an “equal weight” rating and set a $10.00 target price (down from $24.00) on shares of Phreesia in a report on Thursday, May 14th. Canaccord Genuity Group lowered their target price on Phreesia from $22.00 to $16.00 and set a “buy” rating for the company in a report on Thursday, May 28th. DA Davidson reaffirmed a “buy” rating and set a $14.00 target price on shares of Phreesia in a report on Thursday, May 28th. Finally, Truist Financial upped their target price on Phreesia from $11.00 to $12.00 and gave the company a “hold” rating in a report on Thursday, May 28th.

Insider Buying and Selling

In related news, insider David Linetsky sold 8,332 shares of the stock in a transaction that occurred on Friday, April 10th. The stock was sold at an average price of $8.07, for a total value of $67,239.24. Following the completion of the transaction, the insider directly owned 224,056 shares of the company’s stock, valued at $1,808,131.92. This represents a 3.59% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, General Counsel Allison C. Hoffman sold 14,483 shares of the stock in a transaction that occurred on Friday, April 10th. The stock was sold at an average price of $8.07, for a total value of $116,877.81. Following the completion of the transaction, the general counsel directly owned 163,485 shares of the company’s stock, valued at $1,319,323.95. This trade represents a 8.14% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 42,927 shares of company stock valued at $368,022 in the last three months. 5.20% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Phreesia

Institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its position in Phreesia by 8.3% in the third quarter. Vanguard Group Inc. now owns 5,704,786 shares of the company’s stock worth $134,177,000 after purchasing an additional 437,462 shares during the period. Greenhouse Funds LLLP lifted its position in Phreesia by 16.8% in the third quarter. Greenhouse Funds LLLP now owns 3,882,527 shares of the company’s stock worth $91,317,000 after purchasing an additional 557,265 shares during the period. SG Americas Securities LLC acquired a new stake in Phreesia in the fourth quarter worth approximately $1,203,000. Tudor Investment Corp ET AL acquired a new stake in Phreesia in the third quarter worth approximately $4,173,000. Finally, King Luther Capital Management Corp lifted its position in Phreesia by 172.6% in the fourth quarter. King Luther Capital Management Corp now owns 268,314 shares of the company’s stock worth $4,540,000 after purchasing an additional 169,900 shares during the period. 92.10% of the stock is currently owned by institutional investors and hedge funds.

Phreesia Trading Up 1.9%

NYSE:PHR opened at $10.27 on Thursday. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.76 and a current ratio of 1.76. Phreesia has a one year low of $7.77 and a one year high of $32.76. The business’s 50-day simple moving average is $9.38 and its 200 day simple moving average is $11.90. The stock has a market cap of $634.48 million, a price-to-earnings ratio of 68.43 and a beta of 0.91.

Phreesia (NYSE:PHR) last announced its quarterly earnings data on Wednesday, May 27th. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of $0.02 by $0.03. The firm had revenue of $130.94 million during the quarter, compared to analyst estimates of $130.08 million. Phreesia had a return on equity of 5.13% and a net margin of 1.85%.Phreesia’s quarterly revenue was up 12.9% on a year-over-year basis. During the same period in the previous year, the company earned ($0.07) earnings per share. As a group, sell-side analysts predict that Phreesia will post 0.35 earnings per share for the current fiscal year.

Phreesia News Summary

Here are the key news stories impacting Phreesia this week:

• Positive Sentiment: Phreesia’s most recently reported quarter topped analyst expectations on both earnings and revenue, with year-over-year revenue growth of 12.9%, reinforcing the view that the business is still growing. Phreesia stock and earnings background
• Neutral Sentiment: Several law firms, including Rosen, Faruqi & Faruqi, Schall, DJS, Howard G. Smith, and Bronstein, Gewirtz & Grossman, issued deadline reminders and plaintiff solicitations related to a securities class action against Phreesia, with the lead-plaintiff deadline set for July 13, 2026. Phreesia lawsuit deadline article
• Negative Sentiment: The class-action allegations create legal overhang for Phreesia, which can weigh on investor confidence as shareholders assess potential liability, distraction, and reputational risk. Phreesia securities lawsuit article
• Negative Sentiment: News also highlighted insider selling by a Phreesia director, which may add pressure by signaling reduced insider conviction. Phreesia insider selling article

About Phreesia

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.